|Articles|April 8, 2019
Utilizing an Integrated, Multi-Channel Approach Can Improve Access for Oncology Products
Author(s)McKesson Life Sciences
How biopharma companies can pursue multiple channels to enhance access to segmented markets.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure
2
President Trump Set to Nominate Heidi Overton as FDA Commissioner
3
When Drug Pricing Becomes Trade Policy
4
From Pilot to Profit: How Pharma Leaders Are Scaling AI Across the Drug Lifecycle
5